柳工(000528.SZ):柳工有限就增資擴股暨股權轉讓項目與戰略投資者及常州嘉佑簽訂了協議
格隆匯 12 月 16日丨柳工(000528.SZ)公佈,公司於2020年12月15日收到控股股東廣西柳工集團機械有限公司(“柳工有限”)通知,柳工有限就增資擴股暨股權轉讓項目與戰略投資者及常州嘉佑企業管理合夥企業(有限合夥)(“常州嘉佑”)簽訂了《廣西柳工集團機械有限公司增資擴股及股權轉讓協議》,完成了工商變更工作。
此次柳工集團混改增資擴股暨股權轉讓項目完成後,柳工集團持有公司控股股東柳工有限的比例不低於51%,仍為公司間接控股股東,公司實際控制人仍為廣西壯族自治區人民政府國有資產監督管理委員會。本項目不會導致公司間接控股股東和實際控制人發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.